Geron Corporation [GERN] stock is up 1.00 while the S&P 500 has risen 0.43% on Thursday, 10/15/20. While at the time of this article, GERN ATR is sitting at 0.11, with the beta value at 1.62. This stock’s volatility for the past week remained at 5.00%, while it was 6.13% for the past 30-day period. GERN has risen $0.02 from the previous closing price of $2.00 on volume of 0.92 million shares.
On 1, October 2020, Geron Secures Loan Facility for Up to $75 Million. According to news published on Yahoo Finance, Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it has entered into a loan facility for up to $75 million with Hercules Capital, Inc. (NYSE: HTGC) and Silicon Valley Bank (SVB). The loan facility provides the Company with access to non-dilutive financial resources to support the imetelstat development program, as well as working capital and general corporate purposes.
Analyst Birdseye View:
The most recent analyst activity for Geron Corporation [NASDAQ:GERN] stock was on November 19, 2019, when it was Resumed with a Buy rating from B. Riley FBR, which also raised its 12-month price target on the stock to $4. Before that, on August 03, 2020, Stifel Recapitulated a Buy rating and elevated its amount target to $3. On September 03, 2019, H.C. Wainwright Initiated a Buy rating and boosted its price target on this stock to $4. On August 15, 2019, Cantor Fitzgerald Initiated an Overweight rating and increased its price target to $4. On April 09, 2019, Needham Upgrade a Buy rating and increased its price target to $3. On January 31, 2019, B. Riley FBR Upgrade a Buy rating and boosted its amount target on this stock to $3.25. On October 02, 2018, B. Riley FBR Downgrade a Neutral rating and decreased its target amount on this stock from $5.75 to $1.50. On July 05, 2018, B. Riley FBR Inc. Initiated a Buy rating and improved its amount target to $5.75.
In the past 52 weeks of trading, this stock has oscillated between a low of $0.75 and a peak of $2.40. Right now, according to Wall Street analyst the average 12-month amount target is $4.00. At the most recent market close, shares of Geron Corporation [NASDAQ:GERN] were valued at $2.02.
Geron Corporation [NASDAQ:GERN] most recently reported quarterly sales of 43.0 million, which represented growth of -57.40%. This publicly-traded organization’s revenue is $10,000 per employee, while its income is -$1,490,174 per employee. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -39.08, -43.82, -45.97 and -43.51 respectively.
The Principal structure of this organization shows its whole liability to whole principal at 1.85 and the whole liability to whole assets at 1.54. It shows enduring liability to the whole principal at 1.60 and enduring liability to assets at 0.01 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 1.96 points at 1st support level, the second support level is making up to 1.93. But as of 1st resistance point, this stock is sitting at 2.05 and at 2.11 for 2nd resistance point.
Geron Corporation [GERN] reported its earnings at -$0.06 per share in the fiscal quarter closing of 6/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.06/share signifying the difference of 0 and 0.00% surprise value. Comparing the previous quarter ending of 3/30/2020, the stated earnings were -$0.08 calling estimates for -$0.12/share with the difference of 0.04 depicting the surprise of 33.30%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for Geron Corporation [NASDAQ:GERN] is 11.50. Likewise, the Quick ratio is also the same, showing Cash ratio at 4.96. Now if looking for a valuation of this stock’s amount to sales ratio it’s 562.21 and it’s amount to book ratio is 2.01.
The most recent insider trade was by O’Farrell Elizabeth G., Director, and it was the purchase of 17441.0 shares on Aug 21. O’Farrell Elizabeth G., the Director, completed a purchase of 2200.0 shares on Jan 10. On Jan 10, O’Farrell Elizabeth G., Director, completed a purchase of 800.0 shares.